Compare Sana Biotechnology Inc (SANA) vs Solaris Energy Infrastructure Inc. Class A Common Stock (SEI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Solaris Energy Infrastructure Inc. Class A Common Stock — how do they compare? Sana Biotechnology Inc trades at $2.44 (market cap $697.51M), while Solaris Energy Infrastructure Inc. Class A Common Stock trades at $62.89 (market cap $4.57B). The key difference: Solaris Energy Infrastructure Inc. Class A Common Stock is far larger — about 6.6× Sana Biotechnology Inc's market cap, and Solaris Energy Infrastructure Inc. Class A Common Stock pays a 0.69% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 24 Days and Solaris Energy Infrastructure Inc. Class A Common Stock for 0 Days on average.
| SANA | SEI | |
|---|---|---|
Market Cap | $697.51M | $4.57B |
Volume | 2,763,583 | 5,269,521 |
Sector | Health | Energy |
52-Week High | $5.92 | $82.88 |
52-Week Low | $2.33 | $40.64 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $610.76M | $6.26B |
Dividend Yield | — | 0.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA trades at $2.44, up 1.24% on the day, with a bearish technical signal but bullish oscillators. The company is pre-revenue with significant losses, reporting a net loss of $244.17 million in 2025 and negative cash flow from operations. Analyst consensus is strongly positive with a $8.50 price target, and recent news highlights active participation in investor conferences and a key publication in The New England Journal of Medicine.
The stock presents a high-risk, high-reward opportunity. Strong analyst buy ratings and promising clinical developments contrast with substantial financial losses and negative profitability metrics. The primary investment thesis hinges on the company's pipeline success, while near-term risks include cash burn and execution challenges in bringing therapies to market.
SEI (Solaris Energy Infrastructure) trades at $77.83, down 1.83% today, but maintains strong analyst support with 9 unanimous buy ratings and a $100.56 consensus price target. The stock shows positive momentum with three consecutive quarterly earnings beats and projected revenue growth from $622M in 2025 to $762M in 2026. Recent technical analysis indicates neutral signals with support at $76 and resistance at $79.
The outlook remains positive given strong earnings performance and expansion initiatives, though elevated valuation ratios (P/E of 98.52) and significant debt issuance ($1.25B notes) present risks. The upcoming Q3 2026 earnings report on October 21 will be crucial for validating growth trajectory amid energy sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Solaris Energy Infrastructure Inc. Class A Common Stock
Solaris Energy Infrastructure, Inc. provides mobile power generation, control, and distribution equipment and logistics equipment for managing raw materials at well sites, operating through its Solaris Power Solutions and Solaris Logistics Solutions segments for data center, energy, commercial, and industrial customers.
Read more on SEI →
